Home > Insider Trading > Filing (0001209191-21-004291)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
742112	Invacare Corp	IVC	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	952680965

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1453022	Anthony Laplaca	One Invacare Way Elyria OH 44035	Sr. Vp And General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Disposition	2021-01-15	7,500	$9.93	75,869	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Shares	Employee Stock Option (Right to Buy)	$0.00			83,133	83,133	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	83,133	83,133	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.805 to $10.22, inclusive. The reporting person undertakes to provide to Invacare Corporation, any security holder of Invacare Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
The reporting person holds previously reported options to buy 83,133 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan and the Invacare Corporation 2013 Equity Compensation Plan, granted in reliance upon the exemption provided by Rule 16b-3. These options were granted between September 2, 2011 and March 16, 2017, at exercise prices between $12.15 to $24.45 per share, will expire between September 2, 2021 and March 16, 2027, and became exercisable between September 30, 2012 and February 19, 2020.
The current balance reflects the expiration of 12,000 options on August 18, 2020.